Anti-RAB10 (phospho T73) antibody [MJF-R21] (ab230261)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [MJF-R21] to RAB10 (phospho T73)
- Suitable for: WB, Dot blot
- Knockout validated
- Reacts with: Mouse, Human, Recombinant fragment
Overview
-
Product name
Anti-RAB10 (phospho T73) antibody [MJF-R21]
See all RAB10 primary antibodies -
Description
Rabbit monoclonal [MJF-R21] to RAB10 (phospho T73) -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species Dot Recombinant fragmentWB MouseHumanRecombinant fragment -
Immunogen
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: Wild-type MEF whole cell lysate; LRRK2 [R1441C] knock-in MEF whole cell lysate. Dot Blot: Rab10 (phospho T73) peptide.
-
General notes
Please see PMID: 29127256. Lis P et al. Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase. Biochem J 475:1-22 (2018).
This antibody was developed with support from The Michael J. Fox Foundation.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.01% Sodium azide
Constituents: PBS, 40% Glycerol, 0.05% BSA -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
MJF-R21 -
Isotype
IgG -
Research areas
Images
-
All lanes : Anti-RAB10 (phospho T73) antibody [MJF-R21] (ab230261) at 1/1000 dilution
Lane 1 : Wild-type MEF (mouse embryonic fibroblast cell line) whole cell lysate
Lane 2 : Wild-type MEF treated with 100 nM MLi-2 for 90 minutes, whole cell lysate
Lane 3 : LRRK2 [R1441C] knock-in MEF whole cell lysate
Lane 4 : LRRK2 [R1441C] knock-in MEF treated with 100 nM MLi-2 for 90 minutes, whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution
Developed using the ECL technique.
Predicted band size: 23 kDa
Observed band size: 23 kDa
Exposure time: 3 minutesBlocking/Dilution buffer: 5% NFDM/TBST.
The LRRK2 pathogenic mutation R1441C increases LRRK2 activity and markedly elevates Rab10 phosphorylation in MEF (mouse embryonic fibroblasts).
The expression pattern is consistent with the literature (PMID: 29127256).
The cell lysates were kindly provided by our collaborator, Dr. Dario Alessi.
-
All lanes : Anti-RAB10 (phospho T73) antibody [MJF-R21] (ab230261) at 1/1000 dilution
Lane 1 : Wild-type A549 (human lung carcinoma cell line) whole cell lysate
Lane 2 : Wild-type A549 treated with 100 nM MLi-2 for 90 minutes, whole cell lysate
Lane 3 : Rab8A knock-out A549 whole cell lysate
Lane 4 : Rab8A knock-out A549 treated with 100 nM MLi-2 for 90 minutes, whole cell lysate
Lane 5 : Rab10 knock-out A549 whole cell lysate
Lane 6 : Rab10 knock-out A549 treated with 100 nM MLi-2 for 90 minutes, whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : HRP-labeled secondary antibody at 1/2500 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDaBlocking buffer: 5% NFDM/TBST.
Dilution buffer: 5% BSA/TBST.
The images were kindly provided by our collaborator, Dr. Dario Alessi, and have been published (PMID: 29127256).
Scanned with Licor Odyssey CLx.
-
All lanes : Anti-RAB10 (phospho T73) antibody [MJF-R21] (ab230261) at 1/1000 dilution
Lane 1 : HEK-293 (human epithelial cell line from embryonic kidney) cells transfected with LRRK2 [Y1699C] and HA-tagged Rab3A expression vectors, were treated with 150 nM MLi-2 for 90 minutes, whole cell lysate
Lane 2 : HEK-293 cells transfected with LRRK2 [Y1699C] and HA-tagged Rab8A expression vectors, were treated with 150 nM MLi-2 for 90 minutes, whole cell lysate
Lane 3 : HEK-293 cells transfected with LRRK2 [Y1699C] and HA-tagged Rab10 expression vectors, were treated with 150 nM MLi-2 for 90 minutes, whole cell lysate
Lane 4 : HEK-293 cells transfected with LRRK2 [Y1699C] and HA-tagged Rab35 expression vectors, were treated with 150 nM MLi-2 for 90 minutes, whole cell lysate
Lane 5 : HEK-293 cells transfected with LRRK2[Y1699C] and HA-tagged Rab43 expression vectors, were treated with 150 nM MLi-2 for 90 minutes, whole cell lysate
Lysates/proteins at 0.1 µg per lane.
Secondary
All lanes : IRDye 800CW secondary antibody at 1/25000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDaBlocking buffer: 5% NFDM/TBST.
Dilution buffer: 5% BSA/TBST.
The LRRK2 pathogenic mutation Y1699C increases LRRK2 activity and markedly elevates the phosphorylation of Rab proteins.
The images were kindly provided by our collaborator Dr. Dario Alessi, and have been published (PMID: 29127256).
Scanned with Licor Odyssey CLx.
-
Dot blot analysis of Rab10 (phospho T73) labeled with ab230261 at 1/1000 dilution.
Lane 1: Rab10 (phospho T73) peptide;
Lane 2: Rab10 non-phospho peptide.
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100,000 dilution was used as secondary antibody.
Blocking/Dilution buffer: 5% NFDM/TBST.
Exposure time: 32 seconds.
-